Rapid Relief

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older should carefully remove the backing from the patch and apply the sticky side to the affected area. The patch should not be left on the skin for more than a total of 8 hours per day. Application may be repeated as necessary, but should not exceed 3 times daily. Each patch is for single use only and must be discarded after use.

For children under 12 years of age, the product is not recommended, and consultation with a physician is advised. It is important to supervise children when they are using this product to ensure safe and appropriate application.

Contraindications

Use of this product is contraindicated in the following situations:

Application on wounds, cuts, damaged, or infected skin is prohibited due to the risk of exacerbating the condition. The product should not be applied to the eyes, mouth, genitals, or any mucous membranes, as this may lead to irritation or adverse reactions. Additionally, tight bandaging or the use of heating pads, including electric heating pads, is contraindicated, as this may cause excessive skin irritation or burns. Concurrent use with other topical analgesics is also not recommended, as it may increase the risk of adverse effects.

Warnings and Precautions

For external use only. This product should be utilized strictly as directed to minimize the risk of adverse effects.

General Precautions There have been rare reports of serious burns associated with the use of similar products. To prevent excessive skin irritation or burns, it is imperative not to bandage the area tightly or use heating pads, including electric heating pads, in conjunction with the product. Care should be taken to avoid contact with the eyes and mucous membranes, and the product must not be applied to wounds or damaged skin. Concurrent use with other topical analgesics is contraindicated.

Emergency Medical Help Instructions In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Stop Taking and Call Your Doctor Instructions Healthcare professionals should advise patients to discontinue use and seek medical attention if any of the following occur: worsening of the condition, presence of redness, development of irritation, persistence of symptoms beyond 7 days, recurrence of symptoms after initial improvement, or any signs of skin injury, including pain, swelling, or blistering at the application site, as these may indicate serious burns.

Side Effects

Patients should be aware that the product is intended for external use only. In the event of worsening conditions, the presence of redness, the development of irritation, or if symptoms persist for more than 7 days or resolve and then recur within a few days, it is advised to discontinue use and consult a healthcare professional.

Additionally, patients should seek medical attention if they experience signs of skin injury, which may include pain, swelling, or blistering at the site of application. Although rare, serious burns can occur, and prompt medical evaluation is recommended in such cases.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Rapid Relief (cold relief patch 5% menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this product without consulting a physician. It is essential to supervise children during the use of this product to ensure safety and proper administration.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to seek medical advice to weigh the benefits and risks associated with the use of this medication during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and individualized patient assessment. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. Healthcare professionals should also consider contacting a poison control center for additional guidance on the management of overdose cases.

It is crucial to document any instances of suspected overdose and report them to the appropriate regulatory authorities to enhance the understanding of the medication's safety profile.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Serious burns have been reported in rare cases associated with the use of products of this type. While these events are infrequent, they are considered significant and warrant attention in the context of postmarketing surveillance.

Patient Counseling

Healthcare providers should advise patients to use the product only as directed and to be aware of the potential for serious burns, which, although rare, have been reported with similar products. Patients should be instructed to seek medical help or contact a Poison Control Center immediately if the product is swallowed.

It is important to inform patients not to bandage the area tightly or use the product in conjunction with heating pads, including electric heating pads, as this may lead to excessive skin irritation or burns. Patients should also be cautioned to avoid contact with eyes and mucous membranes, and to refrain from applying the product to wounds or damaged skin.

Healthcare providers should emphasize that the product should not be used simultaneously with other topical analgesics. Patients should be advised to stop using the product and consult a doctor if their condition worsens, if redness or irritation develops, or if symptoms persist for more than 7 days or clear up and then recur within a few days. Additionally, patients should be instructed to seek medical advice if they experience any signs of skin injury, such as pain, swelling, or blistering at the application site, as these may indicate serious burns.

Storage and Handling

The product is supplied in configurations that are compliant with the National Drug Code (NDC) standards. It should be stored at a temperature range of 15-30℃ (59-86℉) to maintain its efficacy. It is essential to keep the product out of reach of children to ensure safety. Proper handling and storage conditions must be adhered to in order to preserve the integrity of the product.

Additional Clinical Information

The product is administered topically. For adults and children aged 12 years and older, the patch should be applied to the affected area by carefully removing the backing and placing the sticky side against the skin. It should not remain on the skin for more than 8 hours in total per day, and can be repeated as necessary, up to three times daily. After a single use, the patch must be discarded. For children under 12 years of age, use is not recommended without consulting a physician, and adult supervision is advised during application.

Clinicians should counsel patients to consult a health professional if they are pregnant or breastfeeding before using the product. It is important to keep the product out of reach of children, and in the event of ingestion, medical assistance or contact with a Poison Control Center should be sought immediately.

Drug Information (PDF)

This file contains official product information for Rapid Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)